Immune escape by Epstein–Barr virus associated malignancies
C Münz, A Moormann - Seminars in cancer biology, 2008 - Elsevier
Persistent Epstein–Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein–Barr virus associated malignancies
C Münz, A Moormann - Seminars in Cancer Biology, 2008 - infona.pl
Persistent Epstein–Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …
[引用][C] Immune escape by Epstein–Barr virus associated malignancies
C Münz, A Moormann - Seminars in Cancer Biology, 2008 - cir.nii.ac.jp
Immune escape by Epstein-Barr virus associated malignancies.
C Münz, A Moormann - Seminars in cancer biology, 2008 - sonar.ch
English Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of
virus carriers, despite the potent growth transforming potential of this virus. The increased …
virus carriers, despite the potent growth transforming potential of this virus. The increased …
[HTML][HTML] Immune escape by Epstein Barr virus associated malignancies
C Münz, A Moormann - Seminars in cancer biology, 2008 - ncbi.nlm.nih.gov
Abstract Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority
of virus carriers, despite the potent growth transforming potential of this virus. The increased …
of virus carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein-Barr virus associated malignancies.
C Münz, A Moormann - Seminars in Cancer Biology, 2008 - europepmc.org
Abstract Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority
of virus carriers, despite the potent growth transforming potential of this virus. The increased …
of virus carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein-Barr virus associated malignancies
C Münz, A Moormann - Seminars in Cancer Biology, 2008 - zora.uzh.ch
Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein-Barr virus associated malignancies.
C Münz, A Moormann - Seminars in cancer biology, 2008 - folia.unifr.ch
English Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of
virus carriers, despite the potent growth transforming potential of this virus. The increased …
virus carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein-Barr virus associated malignancies
C Munz, AM Moormann - 2008 - repository.escholarship.umassmed …
Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …
Immune escape by Epstein-Barr virus associated malignancies
C Münz, A Moormann - Seminars in cancer biology, 2008 - pubmed.ncbi.nlm.nih.gov
Persistent Epstein-Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …